Tower Research Capital LLC (Trc) Aditxt, Inc. Transaction History

Tower Research Capital LLC (Trc)

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.13 - $0.46 $5,367 - $18,991	41,286 Added 278.58%	56,106 $8,000
Q1 2022 May 12, 2022	BUY	$0.34 - $0.58 $5,038 - $8,595	14,820 New	14,820 $7,000
Q4 2021 Feb 14, 2022	SELL	$0.54 - $2.51 $247 - $1,152	-459 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.54 - $3.04 $706 - $1,395	459 New	459 $1,000
Q2 2021 Aug 16, 2021	SELL	$2.2 - $3.2 $9,050 - $13,164	-4,114 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.08 - $5.26 $7,448 - $18,836	3,581 Added 671.86%	4,114 $11,000
Q4 2020 Feb 16, 2021	SELL	$1.89 - $2.48 $26,915 - $35,317	-14,241 Reduced 96.39%	533 $1,000
Q3 2020 Nov 16, 2020	BUY	$1.7 - $7.6 $25,115 - $112,282	14,774 New	14,774 $29,000

Ticker ADTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,161,130
Market Cap $749K
Description
Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immuno...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.